Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 01, 2023

BUY
$9.86 - $23.83 $387,734 - $937,090
39,324 Added 49.64%
118,540 $1.2 Million
Q3 2022

Oct 28, 2022

SELL
$21.04 - $36.06 $402,432 - $689,719
-19,127 Reduced 19.45%
79,216 $1.78 Million
Q2 2022

Aug 04, 2022

BUY
$17.78 - $42.39 $392,671 - $936,183
22,085 Added 28.96%
98,343 $2.44 Million
Q1 2022

May 03, 2022

BUY
$29.67 - $60.28 $742,284 - $1.51 Million
25,018 Added 48.83%
76,258 $2.96 Million
Q4 2021

Jan 31, 2022

BUY
$47.84 - $64.34 $155,240 - $208,783
3,245 Added 6.76%
51,240 $3 Million
Q3 2021

Oct 27, 2021

SELL
$59.27 - $95.73 $14,698 - $23,741
-248 Reduced 0.51%
47,995 $2.85 Million
Q2 2021

Jul 23, 2021

BUY
$67.25 - $92.52 $300,809 - $413,841
4,473 Added 10.22%
48,243 $4.19 Million
Q1 2021

Apr 27, 2021

SELL
$72.16 - $117.4 $89,261 - $145,223
-1,237 Reduced 2.75%
43,770 $3.61 Million
Q4 2020

Feb 03, 2021

SELL
$38.09 - $100.95 $764,542 - $2.03 Million
-20,072 Reduced 30.84%
45,007 $4.09 Million
Q3 2020

Oct 27, 2020

SELL
$30.41 - $40.5 $58,904 - $78,448
-1,937 Reduced 2.89%
65,079 $2.6 Million
Q2 2020

Aug 04, 2020

BUY
$20.21 - $35.23 $1.35 Million - $2.36 Million
67,016 New
67,016 $2.3 Million
Q4 2019

Jan 31, 2020

SELL
$13.39 - $20.73 $1.43 Million - $2.21 Million
-106,800 Closed
0 $0
Q3 2019

Oct 23, 2019

BUY
$15.47 - $22.5 $1.65 Million - $2.4 Million
106,800 New
106,800 $1.66 Million

Others Institutions Holding FATE

About FATE THERAPEUTICS INC


  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $123M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.